Methacort 40 Interactions
There are 597 drugs known to interact with Methacort 40 (methylprednisolone), along with 23 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 100 are major, 460 are moderate, and 37 are minor.
- View all 597 medications that may interact with Methacort 40
- View Methacort 40 alcohol/food interactions (3)
- View Methacort 40 disease interactions (23)
Most frequently checked interactions
View interaction reports for Methacort 40 (methylprednisolone) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- Boniva (ibandronate)
- calcium citrate
- Centrum Silver (multivitamin with minerals)
- Cymbalta (duloxetine)
- Depakote (divalproex sodium)
- Geodon (ziprasidone)
- Lamictal (lamotrigine)
- Lamisil (terbinafine)
- levothyroxine
- lithium
- Paxil (paroxetine)
- pravastatin
- Singulair (montelukast)
- Topamax (topiramate)
- Vitamin D2 (ergocalciferol)
- Wellbutrin (bupropion)
Methacort 40 alcohol/food interactions
There are 3 alcohol/food interactions with Methacort 40 (methylprednisolone).
Methacort 40 disease interactions
There are 23 disease interactions with Methacort 40 (methylprednisolone) which include:
- infections
- prematurity
- (+) tuberculin test
- cirrhosis
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hyperlipidemia
- hypothyroidism
- liver disease
- MI
- myasthenia gravis
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- scleroderma
- strongyloidiasis
- thromboembolism
More about Methacort 40 (methylprednisolone)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: glucocorticoids
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.